File Download

There are no files associated with this item.

Supplementary

Conference Paper: Complementary and alternative medicine use in the first trimester: safety perceptions and preference of pregnant women

TitleComplementary and alternative medicine use in the first trimester: safety perceptions and preference of pregnant women
Authors
KeywordsPregnant
Complementary and alternative medicine
epidemiology
PublisherThe Pharmaceutical Society of Hong Kong. The Journal's web site is located at http://www.pshk.hk/main.php?id=62
Citation
The 8th Asian Conference on Pharmacoepidemiology (ACPE 2013), Hong Kong, China, 25-27 October 2013. In Hong Kong Pharmaceutical Journal, 2013, v. 20 n. 3, p. 138 How to Cite?
AbstractAim/Objectives: To assess the use of complementary and alternative medicines (CAM) during the fi rst trimester, the perceptions of the women on the safety of CAM and their preferences for CAM. Methods: This study was carried out in two London teaching hospitals. Expectant mothers were interviewed using a structured questionnaire to ascertain their CAM use during the fi rst trimester; perception of CAM safety in comparison to conventional medicines; and preference for CAM in treating medical conditions. Results: Six hundred and seven women were approached of which 560 participated in the study; their age was 31.9 ± 5.1 years. 40.5% of them had used at least one form of CAM in the fi rst trimester. When asked to compare the safety of CAM to conventional medicines, 12.3% felt CAM is safer, 27% thought both CAM and conventional medicines are equally safe, 15.9% felt CAM is less safe while 44.8% felt they did not know about the safety of CAM compared to conventional medicines. In treating a new medical condition, 17.1% of the participants would choose CAM rather than conventional medicines as their most preferred therapy. Conclusions: These fi ndings demonstrate that a considerable proportion of the women had used CAM in early pregnancy. Although almost half of the participants did not know about the safety of CAM compared to conventional medicines, nearly a fi fth would want CAM as a fi rst choice therapy. Therefore, routine counselling about CAM is important during antenatal assessments. Further research is also necessary to better understand CAM use in pregnancy.
DescriptionConference Theme: Applying pharmacoepidemiology to improve health care in Asia
Oral Presentation - Genetics, Pregnancy and Paediatric Issues
Persistent Identifierhttp://hdl.handle.net/10722/204450
ISSN

 

DC FieldValueLanguage
dc.contributor.authorWahab, Men_US
dc.contributor.authorSutcliffe, Aen_US
dc.contributor.authorWong, ICKen_US
dc.contributor.authorJani, Yen_US
dc.date.accessioned2014-09-19T23:52:22Z-
dc.date.available2014-09-19T23:52:22Z-
dc.identifier.citationThe 8th Asian Conference on Pharmacoepidemiology (ACPE 2013), Hong Kong, China, 25-27 October 2013. In Hong Kong Pharmaceutical Journal, 2013, v. 20 n. 3, p. 138en_US
dc.identifier.issn1727-2874-
dc.identifier.urihttp://hdl.handle.net/10722/204450-
dc.descriptionConference Theme: Applying pharmacoepidemiology to improve health care in Asia-
dc.descriptionOral Presentation - Genetics, Pregnancy and Paediatric Issues-
dc.description.abstractAim/Objectives: To assess the use of complementary and alternative medicines (CAM) during the fi rst trimester, the perceptions of the women on the safety of CAM and their preferences for CAM. Methods: This study was carried out in two London teaching hospitals. Expectant mothers were interviewed using a structured questionnaire to ascertain their CAM use during the fi rst trimester; perception of CAM safety in comparison to conventional medicines; and preference for CAM in treating medical conditions. Results: Six hundred and seven women were approached of which 560 participated in the study; their age was 31.9 ± 5.1 years. 40.5% of them had used at least one form of CAM in the fi rst trimester. When asked to compare the safety of CAM to conventional medicines, 12.3% felt CAM is safer, 27% thought both CAM and conventional medicines are equally safe, 15.9% felt CAM is less safe while 44.8% felt they did not know about the safety of CAM compared to conventional medicines. In treating a new medical condition, 17.1% of the participants would choose CAM rather than conventional medicines as their most preferred therapy. Conclusions: These fi ndings demonstrate that a considerable proportion of the women had used CAM in early pregnancy. Although almost half of the participants did not know about the safety of CAM compared to conventional medicines, nearly a fi fth would want CAM as a fi rst choice therapy. Therefore, routine counselling about CAM is important during antenatal assessments. Further research is also necessary to better understand CAM use in pregnancy.-
dc.languageengen_US
dc.publisherThe Pharmaceutical Society of Hong Kong. The Journal's web site is located at http://www.pshk.hk/main.php?id=62-
dc.relation.ispartofHong Kong Pharmaceutical Journalen_US
dc.subjectPregnant-
dc.subjectComplementary and alternative medicine-
dc.subjectepidemiology-
dc.titleComplementary and alternative medicine use in the first trimester: safety perceptions and preference of pregnant womenen_US
dc.typeConference_Paperen_US
dc.identifier.emailWong, ICK: wongick@hku.hken_US
dc.identifier.authorityWong, ICK=rp01480en_US
dc.identifier.hkuros239876en_US
dc.identifier.volume20en_US
dc.identifier.issue3en_US
dc.identifier.spage138en_US
dc.identifier.epage138en_US
dc.publisher.placeHong Kong-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats